Zhejiang Medicine Co Ltd (600216) — Tangible Net Worth Ratio

Latest as of March 2026: 94.5%

Zhejiang Medicine Co Ltd (600216) has a Tangible Net Worth Ratio of 94.5% as of March 2026. This metric is calculated by deducting intangible assets (CN¥622.52 Million) from net assets (CN¥11.37 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of Zhejiang Medicine Co Ltd for net asset value and shareholders' equity analysis.

Tangible NW Ratio

94.5%
Tangible equity / total equity

Net Assets (Equity)

CN¥11.37 Billion
CNY

Intangible Assets

CN¥622.52 Million
Goodwill, patents, brand value

Total Assets

CN¥14.18 Billion
CNY

Zhejiang Medicine Co Ltd Tangible Net Worth Ratio (1997–2025)

This chart shows how Zhejiang Medicine Co Ltd's Tangible Net Worth Ratio has changed across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 94.5%, reflecting net assets of CN¥11.37 Billion with intangible assets of CN¥622.52 Million CNY. Also explore net asset momentum of Zhejiang Medicine Co Ltd to track the company's year-over-year net asset growth rate.

Annual Tangible Net Worth Ratio for Zhejiang Medicine Co Ltd (1997–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Medicine Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 600216 market cap overview.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 94.6% CN¥11.09 Billion CN¥603.44 Million CN¥14.09 Billion ▲ +0.9 pp
2024 93.7% CN¥10.87 Billion CN¥684.40 Million CN¥13.80 Billion ▲ +1.2 pp
2023 92.5% CN¥9.99 Billion CN¥744.30 Million CN¥12.78 Billion ▲ +0.2 pp
2022 92.3% CN¥9.71 Billion CN¥747.68 Million CN¥12.43 Billion ▲ +0.2 pp
2021 92.1% CN¥9.18 Billion CN¥728.81 Million CN¥12.53 Billion ▼ -2.8 pp
2020 94.9% CN¥8.03 Billion CN¥409.75 Million CN¥10.50 Billion ▼ -0.2 pp
2019 95.1% CN¥8.25 Billion CN¥406.89 Million CN¥10.36 Billion ▲ +0.1 pp
2018 95.0% CN¥8.08 Billion CN¥407.73 Million CN¥10.05 Billion ▲ +0.2 pp
2017 94.8% CN¥7.78 Billion CN¥406.79 Million CN¥9.79 Billion ▲ +0.8 pp
2016 93.9% CN¥6.99 Billion CN¥424.89 Million CN¥8.81 Billion ▲ +0.1 pp
2015 93.8% CN¥6.62 Billion CN¥409.27 Million CN¥8.25 Billion ▼ -0.9 pp
2014 94.7% CN¥6.56 Billion CN¥347.47 Million CN¥7.87 Billion ▼ -0.1 pp
2013 94.8% CN¥6.48 Billion CN¥335.34 Million CN¥7.56 Billion ▼ -1.9 pp
2012 96.7% CN¥6.20 Billion CN¥203.08 Million CN¥7.06 Billion ▼ -1.6 pp
2011 98.3% CN¥4.40 Billion CN¥75.04 Million CN¥5.20 Billion ▼ -0.7 pp
2010 99.0% CN¥3.86 Billion CN¥38.83 Million CN¥4.64 Billion ▲ +0.4 pp
2009 98.6% CN¥2.86 Billion CN¥40.41 Million CN¥3.88 Billion ▲ +0.9 pp
2008 97.7% CN¥1.81 Billion CN¥42.03 Million CN¥3.26 Billion ▲ +2.7 pp
2007 95.0% CN¥873.73 Million CN¥43.68 Million CN¥2.84 Billion ▼ -1.3 pp
2006 96.4% CN¥777.31 Million CN¥28.37 Million CN¥2.53 Billion ▼ 0.0 pp
2005 96.4% CN¥732.23 Million CN¥26.52 Million CN¥2.21 Billion ▲ +0.8 pp
2004 95.6% CN¥645.68 Million CN¥28.42 Million CN¥1.84 Billion ▼ -0.7 pp
2003 96.3% CN¥628.48 Million CN¥23.26 Million CN¥1.67 Billion ▲ +0.8 pp
2002 95.5% CN¥629.71 Million CN¥28.42 Million CN¥1.64 Billion ▲ +0.2 pp
2001 95.3% CN¥608.50 Million CN¥28.90 Million CN¥1.57 Billion ▼ -3.3 pp
2000 98.5% CN¥635.03 Million CN¥9.35 Million CN¥1.44 Billion ▲ +0.6 pp
1999 97.9% CN¥625.07 Million CN¥12.91 Million CN¥1.72 Billion ▲ +1.7 pp
1998 96.2% CN¥348.61 Million CN¥13.22 Million CN¥1.13 Billion ▼ -2.6 pp
1997 98.8% CN¥304.17 Million CN¥3.57 Million CN¥946.35 Million
pp = percentage points